Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy

about

Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy

Item

http://www.wikidata.org/entity/Q58740330

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@en

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@nl

type

Item

label

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@en

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@nl

prefLabel

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@en

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@nl

P1476

Acquired epidermodysplasia ver ...... sis factor-α inhibitor therapy

@en

P2093

Brittney Schultz

http://www.w3.org/2001/XMLSchema#string

Cuong V Nguyen

http://www.w3.org/2001/XMLSchema#string

Erick Jacobson-Dunlop

http://www.w3.org/2001/XMLSchema#string

P2860

Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study

Acquired epidermodysplasia verruciformis.

Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment.

Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.

Keratinizing odontogenic cyst with verrucous pattern featuring negative human papillomavirus status by polymerase chain reaction.

Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population.

TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis.

Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.

Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.

P304

805-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.JDCR.2018.05.021

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30246133

http://www.w3.org/2001/XMLSchema#string

P921

epidermodysplasia verruciformis

P932

6141641

http://www.w3.org/2001/XMLSchema#string